Chronic News and Research

RSS

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Imagine suffering frequent, extreme and disabling mood swings that won’t go away despite years of different treatments and diagnoses.

26 May 2004

Scientific evidence links mold in homes and buildings to people with chronic asthma symptoms

Scientific evidence links mold and other factors related to damp conditions in homes and buildings to asthma symptoms in some people with the chronic disorder, as well as to coughing, wheezing, and upper respiratory tract symptoms in otherwise healthy people, says a new report from the Institute of Medicine of the National Academies.

25 May 2004

Zengen announces positive results of treatment for vaginal yeast infection

Zengen Inc. announced today positive phase I/II results for its proprietary molecule CZEN-002 for the treatment of vulvovaginal candidiasis (VVC), commonly known as vaginal yeast infection.

25 May 2004

$3.5 million grant to develop AIDS vaccinations

Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.

25 May 2004

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

ALTANA AG’s investigational anti-inflammatory medicine roflumilast improved lung function in patients with Chronic Obstructive Pulmonary Disease (COPD) according to a placebo controlled study presented at the annual meeting of the American Thoracic Society (ATS).

25 May 2004

Some smokers may be genetically predisposed to chronic obstructive pulmonary disease

In her study, Ohar looked at more than 500 men and women age 40 and older who had smoked 20 years or more. She found that a variation of the macrophage scavenger receptor gene (MSR-1) is related to the development of airways obstruction in some patients who smoke cigarettes.

25 May 2004

Vasamed announces patent for a novel pulse oximeter

Vasamed, developer and supplier of hemodynamic monitoring products, announced that the U.S. Patent and Trademark Office granted it a method patent for a novel pulse oximeter that incorporates signals from a laser Doppler velocimeter (LDV) and an impedance cardiograph (ICG) to accomplish the measurement of oxygen saturation.

25 May 2004

Pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in emergency

A study presented today at the 100th International Conference of the American Thoracic Society in Orlando shows pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in the emergency department (ED) or being admitted into the hospital.

25 May 2004

CRT devices used in combination with optimized pharmacologic therapy (OPT) significantly impact patient's quality and length of life

UI Heart Care researchers are among the first in the nation to evaluate the effectiveness of cardiac resynchronization therapy (CRT) devices to reduce the risk of mortality and hospitalization in advanced heart failure patients.

25 May 2004

Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it

“Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it,” says Mariell Jessup, MD, Professor of Medicine and Medical Director of the Heart Failure and Transplantation Program at the Hospital of the University of Pennsylvania (HUP).

24 May 2004

Intensive exercising after menopause may reduce bone loss

Early postmenopausal women with osteoporosis who participate in an intense exercise program may experience reduced bone loss, reduced back pain, and lower cholesterol levels, according to an article in the May 24 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

24 May 2004

Trial shows Daclizumab therapy improves multiple sclerosis outcome

A small clinical trial of patients with multiple sclerosis (MS) who did not respond to interferon alone found that adding the human antibody daclizumab improved patient outcome. Patients who received the combined therapy had a 78 percent reduction in new brain lesions and a 70 percent reduction in total lesions, along with other significant clinical improvements.

24 May 2004

Revolutionary self healing bandage that uses the patient's own cells

A revolutionary type of 'self healing' bandage that uses the patient's own cells is being developed. The technique has already been tried successfully on patients with diabetic ulcers and in the long-term could offer a more effective, quicker and cost efficient way of treating many types of slow-healing wounds such as pressure ulcers.

24 May 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Solvay Pharmaceuticals unveiled this week results from a six-month study of both male and female patients and from a subgroup analysis of males with Irritable Bowel Syndrome with Diarrhea predominance (IBS-D).

24 May 2004

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

New data presented at the American Thoracic Society’s 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.

24 May 2004

Increases in co-payments may reduce the use of medications

Significant increases in co-payments may reduce the use of medications and raise concern about adverse health consequences, according to a study published in the May 19 issue of the Journal of the American Medical Association (JAMA).

22 May 2004

Helminthic therapy, using worm eggs to treat patients with inflammatory bowel disorders

University of Iowa Health Care researchers reported important findings recently at a conference of specialists in New Orleans, La. The findings are from their study of helminthic therapy - using specially prepared worm eggs - to treat patients diagnosed with inflammatory bowel disorders that don't respond to standard treatments.

21 May 2004

Using gene therapy to fight rheumatoid arthritis

Guided by a similar principle, arthritis researchers at the University of Florida and Harvard University hope to use gene therapy to help joint cells pump out a harmless protein that parks in receptor sites, leaving a notorious inflammatory agent “circling the lot” and unable to cause pain, swelling and possible joint damage.

21 May 2004

New treatment for dry eye syndrome (keratoconjunctivitis sicca)

Researchers in the department of ophthalmology at the University of Arizona College of Medicine in Tucson played an important role in the development of Restasis, the first alternative to artificial tears for the treatment of dry eye syndrome.

21 May 2004

Chronic News and Research

Bipolar disorder, one of the illnesses that will be studied and treated at the new Mood Disorders Centre of Excellence

Scientific evidence links mold in homes and buildings to people with chronic asthma symptoms

Zengen announces positive results of treatment for vaginal yeast infection

$3.5 million grant to develop AIDS vaccinations

Anti-inflammatory medicine Roflumilast improved lung function in patients with chronic obstructive pulmonary disease

Some smokers may be genetically predisposed to chronic obstructive pulmonary disease

Vasamed announces patent for a novel pulse oximeter

Pediatric asthma patients given a certain inhaled corticosteroid had a 29 percent lower risk of ending up in emergency

CRT devices used in combination with optimized pharmacologic therapy (OPT) significantly impact patient's quality and length of life

Heart failure is a leading cause of death and nearly 5 million people in the United States suffer from it

Intensive exercising after menopause may reduce bone loss

Trial shows Daclizumab therapy improves multiple sclerosis outcome

Revolutionary self healing bandage that uses the patient's own cells

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Once-daily treatment with Alvesco (ciclesonide) in asthma patients has no effect on normal adrenal function

Increases in co-payments may reduce the use of medications

Helminthic therapy, using worm eggs to treat patients with inflammatory bowel disorders

Using gene therapy to fight rheumatoid arthritis

New treatment for dry eye syndrome (keratoconjunctivitis sicca)

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News